实施人乳头瘤病毒（HPV）疫苗接种政策的挑战。
Challenges of implementing human papillomavirus (HPV) vaccination policy.
作者信息
Raffle Angela E
机构信息
Bristol Primary Care Trust, King Square, Bristol BS2 8EE.
出版信息
BMJ. 2007 Aug 25;335(7616):375-7. doi: 10.1136/bmj.39273.458322.BE.
Abstract
argues that in countries with established cervical screening programmes, HPV vaccination of pre-adolescent girls could bring additional benefit at an affordable cost, but careful planning, adequate education, and integral evaluation will be needed
摘要
认为在已建立宫颈癌筛查项目的国家，对青春期前女孩进行人乳头瘤病毒（HPV）疫苗接种能够以可承受的成本带来额外益处，但需要精心规划、充分教育和综合评估。
相似文献
1
Challenges of implementing human papillomavirus (HPV) vaccination policy.实施人乳头瘤病毒（HPV）疫苗接种政策的挑战。
BMJ. 2007 Aug 25;335(7616):375-7. doi: 10.1136/bmj.39273.458322.BE.
2
The economic impact of HPV vaccines: not just cervical cancer.人乳头瘤病毒疫苗的经济影响：不止于宫颈癌。
Am J Obstet Gynecol. 2008 May;198(5):487-8. doi: 10.1016/j.ajog.2008.03.056.
3
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.在巴西将11岁女孩的人乳头瘤病毒普遍疫苗接种纳入国家免疫规划的成本效益分析。
Vaccine. 2015 May 7;33 Suppl 1:A135-42. doi: 10.1016/j.vaccine.2014.12.031.
4
Policy debate over human papillomavirus vaccines.关于人乳头瘤病毒疫苗的政策辩论。
J Low Genit Tract Dis. 2009 Apr;13(2):128. doi: 10.1097/LGT.0b013e318186facb.
5
A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy.一种评估医疗保健中实物期权价值的新方法：多队列人乳头瘤病毒疫苗接种策略案例。
Clin Ther. 2013 Jul;35(7):904-14. doi: 10.1016/j.clinthera.2013.05.003. Epub 2013 Jun 24.
6
[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].人乳头瘤病毒疫苗接种的效率——基于荷兰成本效益分析的估计
Ned Tijdschr Geneeskd. 2009;153:A356.
7
The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study.最优控制在评估最具成本效益的疫苗接种计划实施中的作用：以 HPV 为例。
Math Biosci. 2011 Jun;231(2):126-34. doi: 10.1016/j.mbs.2011.02.009. Epub 2011 Mar 4.
8
Cost-effectiveness analysis: an essential tool to inform public health policy in cervical cancer prevention.成本效益分析：为宫颈癌预防公共卫生政策提供信息的重要工具。
Vaccine. 2008 Sep 15;26 Suppl 5:F1-2. doi: 10.1016/j.vaccine.2008.05.067.
9
A brief history of economic evaluation for human papillomavirus vaccination policy.人乳头瘤病毒疫苗接种政策经济评估简史
Sex Health. 2010 Sep;7(3):352-8. doi: 10.1071/SH10018.
10
Global human papillomavirus vaccination: can it be cost-effective?全球人乳头瘤病毒疫苗接种：它具有成本效益吗？
BJOG. 2012 Jan;119(2):125-8. doi: 10.1111/j.1471-0528.2011.03090.x.
引用本文的文献
1
HPV Vaccination in Bangladesh: Ethical Views.孟加拉国的 HPV 疫苗接种：伦理观点。
Recent Results Cancer Res. 2021;218:31-37. doi: 10.1007/978-3-030-63749-1_3.
2
A health care professionals training needs assessment for oncology in Uganda.乌干达肿瘤学医疗专业人员培训需求评估。
Hum Resour Health. 2020 Sep 1;18(1):62. doi: 10.1186/s12960-020-00506-7.
3
Health system factors influencing uptake of Human Papilloma Virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda.影响乌干达姆巴莱区 9-15 岁少女接种人乳头瘤病毒（HPV）疫苗的卫生系统因素。
BMC Public Health. 2020 Feb 4;20(1):171. doi: 10.1186/s12889-020-8302-z.
4
Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.中国引入人乳头瘤病毒疫苗所面临的当前问题及未来展望。
Hum Vaccin Immunother. 2019;15(7-8):1533-1540. doi: 10.1080/21645515.2019.1611157. Epub 2019 Jul 16.
5
Ethical issues related to human papillomavirus vaccination programs: an example from Bangladesh.与人类乳头瘤病毒疫苗接种计划相关的伦理问题：以孟加拉国为例。
BMC Med Ethics. 2018 Jun 15;19(Suppl 1):39. doi: 10.1186/s12910-018-0287-0.
6
Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.在乌干达为10至15岁女孩接种人乳头瘤病毒疫苗的可行性。
Afr Health Sci. 2015 Mar;15(1):33-41. doi: 10.4314/ahs.v15i1.5.
7
The paediatric story of human papillomavirus (Review).人乳头瘤病毒的儿科情况（综述）
Oncol Lett. 2014 Aug;8(2):502-506. doi: 10.3892/ol.2014.2226. Epub 2014 Jun 4.
8
Human papilloma virus (HPV) vaccination in childhood: challenges and perspectives.儿童人乳头瘤病毒（HPV）疫苗接种：挑战与前景
Hippokratia. 2011 Oct;15(4):299-303.
9
'A false sense of security'? Understanding the role of the HPV vaccine on future cervical screening behaviour: a qualitative study of UK parents and girls of vaccination age.“虚假的安全感”？理解 HPV 疫苗对未来宫颈癌筛查行为的作用：一项针对英国 HPV 疫苗接种年龄的父母和女孩的定性研究。
J Med Screen. 2011;18(1):41-5. doi: 10.1258/jms.2011.010148.
10
Gardasil® - The New HPV Vaccine: The Right Product, the Right Time? A Commentary.加德西®——新型人乳头瘤病毒疫苗：选对产品，恰逢其时？一篇评论
Healthc Policy. 2010 May;5(4):26-36.
本文引用的文献
1
The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU--preliminary results of a VENICE survey.欧盟国家免疫规划中HPV疫苗和轮状病毒疫苗的现状——威尼斯调查的初步结果
Euro Surveill. 2007 Apr 26;12(4):E070426.1. doi: 10.2807/esw.12.17.03181-en.
2
Papillomavirus vaccines in perspective.人乳头瘤病毒疫苗的前景展望。
Lancet. 2007 Jun 30;369(9580):2135-2137. doi: 10.1016/S0140-6736(07)60947-7.
3
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.预防性佐剂二价L1病毒样颗粒疫苗预防年轻女性感染人乳头瘤病毒16型和18型的疗效：一项III期双盲随机对照试验的中期分析
Lancet. 2007 Jun 30;369(9580):2161-2170. doi: 10.1016/S0140-6736(07)60946-5.
4
Human papillomavirus vaccine--opportunity and challenge.人乳头瘤病毒疫苗——机遇与挑战
N Engl J Med. 2007 May 10;356(19):1990-1. doi: 10.1056/NEJMe078088.
5
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.预防高级别宫颈病变的四价人乳头瘤病毒疫苗。
N Engl J Med. 2007 May 10;356(19):1915-27. doi: 10.1056/NEJMoa061741.
6
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).四价人乳头瘤病毒疫苗：免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.
7
Parental response to the introduction of a vaccine against human papilloma virus.父母对引入人乳头瘤病毒疫苗的反应。
Hum Vaccin. 2006 Nov-Dec;2(6):243-8. doi: 10.4161/hv.2.6.3391. Epub 2006 Nov 12.
8
Chapter 13: Current findings from prophylactic HPV vaccine trials.第13章：预防性人乳头瘤病毒疫苗试验的当前研究结果。
Vaccine. 2006 Aug 31;24 Suppl 3:S3/114-21. doi: 10.1016/j.vaccine.2006.06.014. Epub 2006 Jun 23.
9
Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing.招募22000名青春期女性进入癌症登记随访，以评估人乳头瘤病毒长期疫苗效力：防止猜测。
Int J STD AIDS. 2006 Aug;17(8):517-21. doi: 10.1258/095646206778145550.
10
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial.常规宫颈筛查中的人乳头瘤病毒检测：来自ARTISTIC试验的横断面数据
Br J Cancer. 2006 Jul 3;95(1):56-61. doi: 10.1038/sj.bjc.6603210. Epub 2006 Jun 13.
Zotero 插件